Trillium Therapeutics Inc. TRIL entered into a definitive agreement with pharma giant Pfizer PFE, whereby it will be acquired by the latter. ....For Pfizer, the acquisition is expected to strengthen its hematology portfolio with the addition of Trillium’s next-generation immuno-therapeutics targeting hematological malignancies.
With a quick glance i see that GMDA is by far more advanced than TRIL. Wouldn't you think that GMDA would have been a better option for PFE? (and us naturally)